• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRACLIP DUAL TRIGGER; BREAST TISSUE MARKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRACLIP DUAL TRIGGER; BREAST TISSUE MARKER Back to Search Results
Model Number 864017DL
Device Problems Separation Failure (2547); Therapeutic or Diagnostic Output Failure (3023)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/02/2021
Event Type  malfunction  
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.However, photos were provided for review.The investigation of the reported event is currently underway.(expiry date: 09/2023).
 
Event Description
It was reported that during breast marker placement procedure under ultrasound guidance, the device allegedly had poor quality imaging.There was no reported patient injury.
 
Event Description
It was reported that during breast marker placement procedure under ultrasound guidance, the device allegedly had separation failure.There was no reported patient injury.
 
Manufacturer Narrative
H10: the file was reassessed for reportability and determined to be no longer reportable.Since an initial mdr was submitted, therefore, the file will remain assessed as a malfunction.H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: two electronic photos were provided for review.Two photos represent the wireform present in the needle having blood residue on it.It shows the presence of wireform in the needle.Therefore, based on the photo review, the reported failure separation could not be confirmed based on the provided photo.Therefore, the investigation for the reported separation failure is kept as inconclusive as there was no proper evident provided.One ultraclip dual trigger was returned for evaluation.On visual evaluation, the device appeared to have blood residue and it was noted that the wireform was not returned.And it was further noted the needle was found to be bent and blunt.Due to the nature of the condition, functional evaluation cannot be done.Therefore, the investigation for the reported separation failure is kept as inconclusive as the functional evaluation is not done.A definitive root cause for the alleged separation failure could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 09/2023),.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRACLIP DUAL TRIGGER
Type of Device
BREAST TISSUE MARKER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key12237212
MDR Text Key263845976
Report Number2020394-2021-01403
Device Sequence Number1
Product Code NEU
UDI-Device Identifier00801741032264
UDI-Public(01)00801741032264
Combination Product (y/n)N
PMA/PMN Number
K090547
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/28/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number864017DL
Device Catalogue Number864017DL
Device Lot NumberHUEW2046
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/29/2021
Date Manufacturer Received08/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-